DrugDrug NameDrug Indication
DB12223Squaric acid dibutyl esterNot Available
DB10418Blatella germanicaNot Available
DB10441Rhizopus arrhizus var. arrhizusNot Available
DB10835Ustilago nuda hordeiNot Available
DB14193Ditiocarb ZincDitiocarb Zinc is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
DB14189EthylenediamineEthylenediamine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
DB14199BromothalonilBromothalonil is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
DB14203Disperse Blue 106Not Available
DB10400Dermatophagoides farinaeDermatophagoides farinae extract is an allergen extract indicated as immunotherapy for house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoidesfarinae house dust mites, or skin testing to licensed house dust mite allergen extracts. ODACTRA is approved for use in adults 18 through 65 years of age
DB10401Dermatophagoides pteronyssinusDermatophagoides pteronyssinus is an allergen extract indicated as immunotherapy for house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides pteronyssinus house dust mites, or skin testing to licensed house dust mite allergen extracts. Dermatophagoides pteronyssinus is approved for use in adults 18 through 65 years of age.
DrugDrug NameTargetType